453 related articles for article (PubMed ID: 31219297)
1. Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease.
Jones JD; Burroughs M; Apodaca M; Bunch J
Neuropsychology; 2020 Jan; 34(1):24-30. PubMed ID: 31219297
[TBL] [Abstract][Full Text] [Related]
2. Intraindividual variability in neuropsychological performance predicts longitudinal cortical volume loss in early Parkinson's disease.
Jones JD; Valenzuela YG; Uribe C; Bunch J; Kuhn TP
Neuropsychology; 2022 Sep; 36(6):513-519. PubMed ID: 35377683
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease.
Jones JD; Rahmani E; Garcia E; Jacobs JP
Parkinsonism Relat Disord; 2020 Mar; 72():7-12. PubMed ID: 32058266
[TBL] [Abstract][Full Text] [Related]
4. Intraindividual variability in verbal fluency performance is moderated by and predictive of mild cognitive impairments.
Holtzer R; Jacobs S; Demetriou E
Neuropsychology; 2020 Jan; 34(1):31-42. PubMed ID: 31192656
[TBL] [Abstract][Full Text] [Related]
5. Intraindividual variability in neuropsychological performance predicts cognitive decline and death in HIV.
Anderson AE; Jones JD; Thaler NS; Kuhn TP; Singer EJ; Hinkin CH
Neuropsychology; 2018 Nov; 32(8):966-972. PubMed ID: 30211610
[TBL] [Abstract][Full Text] [Related]
6. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
[TBL] [Abstract][Full Text] [Related]
7. Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.
Jones JD; Kurniadi NE; Kuhn TP; Szymkowicz SM; Bunch J; Rahmani E
Neuropsychology; 2019 Nov; 33(8):1111-1120. PubMed ID: 31343240
[TBL] [Abstract][Full Text] [Related]
8. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.
Hong JY; Yun HJ; Sunwoo MK; Ham JH; Lee JM; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2014 Sep; 20(9):999-1003. PubMed ID: 25001316
[TBL] [Abstract][Full Text] [Related]
10. The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
Young CB; Cholerton B; Smith AM; Shahid-Besanti M; Abdelnour C; Mormino EC; Hu SC; Chung KA; Peterson A; Rosenthal L; Pantelyat A; Dawson TM; Quinn J; Zabetian CP; Montine TJ; Poston KL
Neurology; 2024 Jul; 103(2):e209609. PubMed ID: 38870440
[TBL] [Abstract][Full Text] [Related]
11. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
[TBL] [Abstract][Full Text] [Related]
12. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
[TBL] [Abstract][Full Text] [Related]
13. State anxiety predicts cognitive performance in patients with Parkinson's disease.
Ehgoetz Martens KA; Silveira CRA; Intzandt BN; Almeida QJ
Neuropsychology; 2018 Nov; 32(8):950-957. PubMed ID: 30284873
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan.
Yu RL; Wu RM; Tai CH; Lin CH; Cheng TW; Hua MS
Parkinsonism Relat Disord; 2012 Dec; 18(10):1067-72. PubMed ID: 22749792
[TBL] [Abstract][Full Text] [Related]
15. Visual dysfunction in Parkinson disease without dementia.
Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
[TBL] [Abstract][Full Text] [Related]
16. Prospective memory performance in individuals with Parkinson's disease who have mild cognitive impairment.
Costa A; Peppe A; Zabberoni S; Serafini F; Barban F; Scalici F; Caltagirone C; Carlesimo GA
Neuropsychology; 2015 Sep; 29(5):782-91. PubMed ID: 25643211
[TBL] [Abstract][Full Text] [Related]
17. Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures.
Flannery SL; Jowett T; Garvey A; Cutfield NJ; Machado L
J Clin Exp Neuropsychol; 2018 Dec; 40(10):1062-1073. PubMed ID: 29978753
[TBL] [Abstract][Full Text] [Related]
18. Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?
Alty JE; Cosgrove J; Jamieson S; Smith SL; Possin KL
Clin Neurol Neurosurg; 2015 Dec; 139():244-6. PubMed ID: 26519897
[TBL] [Abstract][Full Text] [Related]
19. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease.
Hong JY; Sunwoo MK; Chung SJ; Ham JH; Lee JE; Sohn YH; Lee PH
Neurobiol Aging; 2014 Jul; 35(7):1739-43. PubMed ID: 24507441
[TBL] [Abstract][Full Text] [Related]
20. CERAD test performance and cognitive impairment in Parkinson's disease.
Karrasch M; Laatu S; Martikainen K; Marttila R
Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
